4D Molecular Therapeutics, Inc. (FDMT)
NASDAQ: FDMT · Real-Time Price · USD
11.60
+0.08 (0.69%)
At close: Jun 26, 2026, 4:00 PM EDT
11.37
-0.23 (-1.98%)
After-hours: Jun 26, 2026, 7:43 PM EDT
4D Molecular Therapeutics Employees
4D Molecular Therapeutics had 196 employees as of December 31, 2025. The number of employees decreased by 31 or -13.66% compared to the previous year.
Employees
196
Change (1Y)
-31
Growth (1Y)
-13.66%
Revenue / Employee
$450,214
Profits / Employee
-$820,903
Market Cap
606.40M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| CorMedix | 191 |
| Prime Medicine | 146 |
| BridgeBio Oncology Therapeutics | 106 |
| Tectonic Therapeutic | 60 |
| Crescent Biopharma | 55 |
| Faeth Therapeutics | 29 |
| Achieve Life Sciences | 28 |
| Bright Minds Biosciences | 26 |
FDMT News
- 10 days ago - 4D Molecular Therapeutics Transcript: AGM 2026 - Transcripts
- 14 days ago - 4DMT Announces New Employment Inducement Grants - GlobeNewsWire
- 18 days ago - 4D Molecular Therapeutics Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Transcripts
- 24 days ago - 4D Molecular Therapeutics Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 4 weeks ago - 4DMT to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 5 weeks ago - 4D Molecular Therapeutics Transcript: RBC Capital Markets Global Healthcare Conference 2026 - Transcripts
- 6 weeks ago - 4D Molecular Therapeutics Transcript: Bank of America Global Healthcare Conference 2026 - Transcripts
- 7 weeks ago - 4D Molecular price target lowered to $33 from $38 at Goldman Sachs - TheFly